Conclusion

PE is uncommon in patients who undergo bariatric surgery, but if left untreated, it increases mortality risk and long-term morbidity. On the other hand, systemic thrombolytic administration as a standard therapeutic approach is considered relatively contraindicated in massive PE that occurs shortly after surgery. Until the development of sufficient evidence, it is reasonable to approach thromboembolic events based on the individual and medical team’s discretion.